换一批
换一批
作者：
STARRT-AKI Investigators [1]
;
Canadian Critical Care Trials Group [1]
;
Australian and New Zealand Intensive Care Society Clinical Trials Group [1]
;
United Kingdom Critical Care Research Group [1]
;
Canadian Nephrology Trials Network [1]
;
Irish Critical Care Trials Group [1]
;
Sean M,Bagshaw [1]
;
Ron,Wald [1]
;
Neill K J,Adhikari [1]
;
Rinaldo,Bellomo [1]
;
Bruno R,da Costa [1]
;
Didier,Dreyfuss [1]
;
Bin,Du [1]
;
Martin P,Gallagher [1]
;
Stéphane,Gaudry [1]
;
Eric A,Hoste [1]
;
François,Lamontagne [2]
;
Michael,Joannidis ;
Giovanni,Landoni ;
Kathleen D,Liu ;
Daniel F,McAuley ;
Shay P,McGuinness ;
Javier A,Neyra ;
Alistair D,Nichol ;
Marlies,Ostermann ;
Paul M,Palevsky ;
Ville,Pettilä ;
Jean-Pierre,Quenot ;
Haibo,Qiu ;
Bram,Rochwerg ;
Antoine G,Schneider ;
Orla M,Smith ;
Fernando,Thomé ;
Kevin E,Thorpe ;
Suvi,Vaara ;
Matthew,Weir ;
Amanda Y,Wang ;
Paul,Young ;
Alexander,Zarbock
作者单位：
From the Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton (S.M.B.), the Division of Nephrology (R.W.), St. Michael's Hospital and the University of Toronto, Li Ka Shing Knowledge Institute (R.W., B.R.C., O.M.S., K.E.T.), Department of Medicine (R.W., O.M.S.), and Applied Health Research Centre (B.R.C., K.E.T.), St. Michael's Hospital, the Dalla Lana School of Public Health (K.E.T.), the Institute of Health Policy, Management, and Evaluation (R.W., B.R.C.), University of Toronto, and the Department of Critical Care Medicine, Sunnybrook Health Sciences Centre and the University of Toronto (N.K.J.A.), Toronto, the Department of Medicine, Université de Sherbrooke and Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Sherbrooke, Sherbrooke, QC (F.L.), the Division of Critical Care, Juravinski Hospital, McMaster University, Hamilton, ON (B.R.), and the Division of Nephrology, London Health Sciences Centre, London, ON (M.W.) - all in Canada; the Department of Intensive Care, Austin Hospital and Royal Melbourne Hospital, School of Medicine, University of Melbourne, Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University (R.B., A.D.N.), Melbourne, VIC, and the George Institute for Global Health, Concord Clinical School, Faculty of Medicine, University of Sydney, Sydney (M.P.G., A.Y.W.) - both in Australia; the Institute of Primary Health Care, University of Bern, Bern (B.R.C.), and the Department of Critical Care Medicine, CHU Vaudois, Lausanne (A.G.S.) - both in Switzerland; Hôpital Louis Mourier (D.D.) and Université Léonard de Vinci (S.G.), INSERM Unité UMR S1155, Sorbonne Université and Université de Paris, Paris, Hôpital Avicenne, Bobigny (S.G.), and Hôpital Universitaire François Mitterrand, Lipness Team, INSERM Research Center Lipids, Nutrition, Cancer-Unité Mixte de Recherche 1231 and Laboratoire d'Excellence LipSTIC, Centre d'Investigation Clinique-Epidemiologie Clinique, CHU Dijon-Bourgogne, and INSERM Centre d'Investigation Clinique 1432, Université de Bourgogne, Dijon (J.-P.Q.) - all in France; the Department of Critical Care Medicine, Peking Union Medical College Hospital, Beijing (B.D.), and the Department of Critical Care Medicine, Zhongda Hospital Southeast University, Nanjing (H.Q.) - both in China; the Department of Intensive Care, University of Ghent, Ghent, Belgium (E.A.H.); the Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria (M.J.); Vita Salute San Raffaele University and IRCCS San Raffaele Scientific Institute, Milan (G.L.); the Divisions of Nephrology and Critical Care Medicine, University of California, San Francisco, San Francisco (K.D.L.); the Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, and the Regional Intensive Care Unit, Royal Victoria Hospital, Belfast (D.F.M.), and King's College London, Guy's and St. Thomas' Hospital, London (M.O.) - both in the United Kingdom; the Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland (S.P.M.), and the Medical Research Institute of New Zealand (S.P.M.) and the Intensive Care Unit, Wellington Regional Hospital and Medical Research Institute of New Zealand (P.Y.), Wellington - both in New Zealand; the Division of Nephrology, Bone and Mineral Metabolism, University of Kentucky, Lexington (J.A.N.); University College Dublin Clinical Research Centre at St. Vincent's University Hospital, Dublin (A.D.N.); the Division of Nephrology, University of Pittsburgh, and Veterans Affairs Pittsburgh Healthcare System, Pittsburgh (P.M.P.); the Department of Intensive Care, University of Helsinki, and Helsinki University Hospital, Helsinki (V.P., S.V.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (F.T.); and the Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany (A.Z.).
[1]
From the Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton (S.M.B.), the Division of Nephrology (R.W.), St. Michael's Hospital and the University of Toronto, Li Ka Shing Knowledge Institute (R.W., B.R.C., O.M.S., K.E.T.), Departme
[2]
主题词
急性肾损伤(Acute Kidney Injury);老年人(Aged);危重病(Critical Illness);人类(Humans);意向治疗分析(Intention to Treat Analysis);中年人(Middle Aged);肾替代疗法(Renal Replacement Therapy);治疗结果(Treatment Outcome)
DOI
10.1056/NEJMoa2000741
PMID
32668114
发布时间
2022-07-26
- 浏览2
The New England journal of medicine
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
